Crystal ranked among the top searched stocks for 4 days in the past month.

As of 12:30 PM on the 3rd, Crystal is trading at 13,650 KRW, down 2.5% from the previous day. This represents a 17.77% decrease compared to June 26. Crystal is known as a specialized company in new drug development, including treatments for arthritis and novel antibiotics.

Over the past 5 days, individual investors have net purchased 121,282 shares, while foreigners and institutions have net sold 137,511 shares and 19,265 shares, respectively.

On July 2, Crystal was a market topic for its "strength due to clinical approval of COVID-19 treatment."

※Source: AI Investment Assistant AI Racciro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing